PANAMA CITY INFECTIOUS DISEASE ASSOCIATES P.A. Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Panama City Infectious Disease Associates P.a.

Access the complete profile.

Panama City Infectious Disease Associates P.a. Fast Facts

Revenue	Less than $1 million    See Exact Annual Revenue
Employees	1 - 10Exact Company Size
Primary Industry	621112 Physicians, Mental Health Specialists
Additional NAICS Codes	621111
Address	2579 Huntcliff Lane Panama City, FL 32405

Note: Revenues for privately held companies are statistical evaluations.




Panama City Infectious Disease Associates P.a.'s Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
• What industry is the company in?

Panama City Infectious Disease Associates P.a. Annual Revenue and Growth Rate

Panama City Infectious Disease Associates P.a.	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Panama City Infectious Disease Associates P.a.'s revenues are gauged from an analysis of company filings.

Panama City Infectious Disease Associates P.a.'s Income Statement (based on Industry Averages)

	$ Millions (Industry Average)
Panama City Infectious Disease Associates P.a. Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Recession Risk

Determine whether Panama City Infectious Disease Associates P.a. grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Panama City Infectious Disease Associates P.a. is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.

Market Share of Panama City Infectious Disease Associates P.a.'s Largest Competitors

A competitive analysis shows these companies are in the same general field as Panama City Infectious Disease Associates P.a., even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
MAYO CLINIC AMBULANCE	Rochester, MN	100
SOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP	Pasadena, CA	49
WEST VIRGINIA UNIVERSITY HOSPITALS	Morgantown, WV	39
PERMANENTE MEDICAL GROUP	Oakland, CA	37
MARSHFIELD CLINIC	Marshfield, WI	13
HEALTHCARE PARTNERS INSTITUTE FOR APPLIED RESEARCH & EDUCATION	El Segundo, CA	10
MHM SERVICES	Sterling, VA	7
MAGELLAN HEALTHCARE	Columbia, MD	5
ALTERNATIVE BEHAVIOR STRATEGIES	Salt Lake City, UT	5

Nearby Competitors

These companies are similar in business line and location to Panama City Infectious Disease Associates P.a.. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
DERMATOLOGY SOLUTIONS GROUP	Panama City, FL	100
HEALTHMARK OF WALTON	Defuniak Springs, FL	39
SOUTHERN ORTHOPEDIC SPECIALISTS P.A.	Panama City, FL	22
ECONFINA CARDIOLOGY GROUP P.A.	Panama City, FL	20
BRAIN & SPINE	Panama City, FL	15
INSTITUTE OF ENDOCRINOLOGY DIABETES HEALTH & HORMONES	Panama City, FL	12

Future Competition: Panama City Infectious Disease Associates P.a.'s Fastest Growing Competitors

These companies are in the same general field as Panama City Infectious Disease Associates P.a. and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)